Citadel Advisors’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.47M | Sell |
608,738
-460,059
| -43% | -$1.11M | ﹤0.01% | 2959 |
|
|
2025
Q1 | $2.36M | Buy |
1,068,797
+1,047,828
| +4,997% | +$2.32M | ﹤0.01% | 2437 |
|
|
2024
Q4 | $114K | Buy |
+20,969
| New | +$114K | ﹤0.01% | 5121 |
|
|
2024
Q3 | – | Sell |
-357,549
| Closed | -$2.56M | – | 6364 |
|
|
2024
Q2 | $2.56M | Buy |
357,549
+87,386
| +32% | +$626K | ﹤0.01% | 2212 |
|
|
2024
Q1 | $2.34M | Sell |
270,163
-875,519
| -76% | -$7.59M | ﹤0.01% | 2355 |
|
|
2023
Q4 | $7.5M | Sell |
1,145,682
-616,448
| -35% | -$4.04M | ﹤0.01% | 1395 |
|
|
2023
Q3 | $17.6M | Buy |
1,762,130
+1,745,774
| +10,674% | +$17.5M | ﹤0.01% | 853 |
|
|
2023
Q2 | $203K | Sell |
16,356
-504,201
| -97% | -$6.27M | ﹤0.01% | 4449 |
|
|
2023
Q1 | $7.29M | Buy |
520,557
+24,275
| +5% | +$340K | ﹤0.01% | 1525 |
|
|
2022
Q4 | $7.1M | Sell |
496,282
-1,327,883
| -73% | -$19M | ﹤0.01% | 1518 |
|
|
2022
Q3 | $46.6M | Buy |
1,824,165
+1,687,956
| +1,239% | +$43.1M | 0.01% | 430 |
|
|
2022
Q2 | $3.87M | Sell |
136,209
-298,682
| -69% | -$8.49M | ﹤0.01% | 2104 |
|
|
2022
Q1 | $15.3M | Buy |
434,891
+187,588
| +76% | +$6.62M | ﹤0.01% | 1092 |
|
|
2021
Q4 | $10.4M | Sell |
247,303
-1,070,096
| -81% | -$44.8M | ﹤0.01% | 1427 |
|
|
2021
Q3 | $64.7M | Buy |
1,317,399
+655,686
| +99% | +$32.2M | 0.01% | 359 |
|
|
2021
Q2 | $27.6M | Buy |
661,713
+341,175
| +106% | +$14.2M | 0.01% | 769 |
|
|
2021
Q1 | $11.4M | Sell |
320,538
-852,991
| -73% | -$30.4M | ﹤0.01% | 1342 |
|
|
2020
Q4 | $32.9M | Buy |
+1,173,529
| New | +$32.9M | 0.01% | 611 |
|